Tag: Prescription Drugs
More Than One in Three Stroke Survivors Have Uncontrolled HTN
80.4 percent of stroke survivors take antihypertensive medications, most commonly ACEi, ARB
Remdesivir Shortages Plague Some Hospitals, Pharmacists Say
One-third of pharmacists report that they do not have enough remdesivir to treat all eligible patients
Adherence to Prophylaxis for EGFRi-Linked Rash Beneficial
Adherence to prophylaxis protocols tied to drop in interventions, toxicity-linked chemo interruptions
Risk for Heart Failure Increased for Women Taking β-Blockers
Difference of 4.6 percent found between women and men in rate of heart failure at presentation for ACS
Baloxavir Protects Household Contacts From Influenza
Percentage of patients in whom clinical influenza developed significantly lower in baloxavir group
Gilead Presents Additional Data on Efficacy of Remdesivir for COVID-19
Pharma company says there is further evidence remdesivir may reduce deaths, hasten recovery
Nemolizumab Beats Placebo for Reduction of Pruritus in Eczema
VAS score reduction greater at week 16 for addition of nemolizumab versus placebo to topical agents
Long-Acting Drug Targeting Capsid Protein Promising for HIV
Reduction of viral load seen nine days after dose; sustained plasma exposure seen for more than six months
February to March 2020 Saw Surge in Hydroxychloroquine Rx
Number of patients receiving hydroxychloroquine, chloroquine prescriptions climbed across the U.S.
Upadacitinib Beats Methotrexate in Early Rheumatoid Arthritis
Significantly better clinical, radiographic, patient-reported outcomes seen with upadacitinib
